| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |